Primary glioblastomas are characterized by EGFR amplification, PTEN mutation and absence of IDH1/2 mutations, while secondary glioblastomas are characterized by TP53 mutations, IDH1/2 mutations and lack of EGFR amplification[41]. The gene discussed is EGFR; the disease is glioblastoma.